Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription Articles published in Circ Res Retrieve available abstracts of 93 articles: HTML format

Single Articles

September 2026
1. HONG J, Gillman S, Pellegrino PR, Zhao G, et al
   Neural Mechanisms of Heart-Lung Crosstalk in Chronic Heart Failure.
   Circ Res. 2026 Sep 24. doi: 10.1161/CIRCRESAHA.126.328216.
   PubMed     Abstract available
   
   
   
2. ZHOU C, Fu L, Yuan T, Li F, et al
   Mast Cell St8sia1 Is a Glyco-Epigenetic Checkpoint Driving Cardiac Remodeling.
   Circ Res. 2026;139:e328171.
   PubMed     Abstract available
   
   
   
3. LINKE WA, Kumper L, Fomin A, Martin I, et al
   Nx3 Is a Z-Disk Structural and Signaling Hub That Is Reduced in Heart Failure.
   Circ Res. 2026 Sep 10. doi: 10.1161/CIRCRESAHA.125.327786.
   PubMed     Abstract available
   
   
   August 2026
4. MEN L, Wang Q, Ren B, Cao Y, et al
   Small Extracellular Vesicles From Cardiomyocytes Activate Microglia Aggravating HFpEF.
   Circ Res. 2026;139:e327765.
   PubMed     Abstract available
   
   
   July 2026
5. DAOU D, Das Gupta S, Anand A, May HI, et al
   TFEB Antagonizes Cardiac Hypertrophy and Failure by Enhancing Lysosomal Capacity and Mitochondrial Function.
   Circ Res. 2026;139:e328083.
   PubMed     Abstract available
   
   
   
6. LI J, Ding S, Yang Z, Wang M, et al
   Metabolomic Profiles and Changes During the 20 Years Preceding Heart Failure.
   Circ Res. 2026 Jul 24. doi: 10.1161/CIRCRESAHA.126.328542.
   PubMed     Abstract available
   
   
   
7. PATEL TA, Rose J, Katsurada K, Yada T, et al
   GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight.
   Circ Res. 2026;139:e327683.
   PubMed     Abstract available
   
   
   June 2026
8. GOLDBERG IJ, Young ME, Schulze PC, Drosatos K, et al
   Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.
   Circ Res. 2026;138:e327471.
   PubMed     Abstract available
   
   
   May 2026
9. HEGYI B, Angsutararux P, Chakouri N, Mahling RW, et al
   Targeting Arrhythmogenic Late Sodium Current by FHF1(A)-Derivative FixR in Heart Failure Cardiomyocytes.
   Circ Res. 2026 May 26:10.1161/CIRCRESAHA.126.328204.
   PubMed     Abstract available
   
   
   
10. MERAL D, Mamazhakypov A, Koca D, Mukherjee D, et al
    Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction.
    Circ Res. 2026;138:e327301.
    PubMed     Abstract available
    
    
    
11. HAHN VS, Chaffin M, Simonson B, Jenkin SC, et al
    Single Cell Analysis of Human Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2026 May 15. doi: 10.1161/CIRCRESAHA.125.327433.
    PubMed     Abstract available
    
    
    
12. NGUYEN VB, Kapiloff MS
    AH001: A New Drug Targeting RhoA in Heart Failure.
    Circ Res. 2026;138:e328631.
    PubMed    
    
    
    April 2026
13. SCHANBACHER C, Lorenz K
    Phosphoinositides in Chronic Ang II Signaling: PTEN-A Target in Heart Failure?
    Circ Res. 2026;138:e328513.
    PubMed    
    
    
    
14. WESTHOFF M, Voelker TL, Del Villar SG, Thai PN, et al
    Phosphoinositide Depletion and Compensatory Phospho-Signaling in Angiotensin II-Induced Heart Disease.
    Circ Res. 2026;138:e327896.
    PubMed     Abstract available
    
    
    
15. WANG X, Han S, Zhang G, Huang X, et al
    ESCRT-Mediated Machinery Directly Drives Cardiac T-tubule Formation.
    Circ Res. 2026;138:e327453.
    PubMed     Abstract available
    
    
    March 2026
16. RATNAVADIVEL S, Zhang J, Sheikh F
    Signal Override: Precision Editing of Protein Kinase Calpha in Heart Failure.
    Circ Res. 2026;138:e328024.
    PubMed    
    
    
    
17. XUE M, Liang Y, Yuan Z, Liu X, et al
    Inhibiting RhoA Activation Via GDP-State Stabilization to Relieve Heart Failure.
    Circ Res. 2026 Mar 20. doi: 10.1161/CIRCRESAHA.125.327107.
    PubMed     Abstract available
    
    
    
18. HORNER KB, Mutchler AL
    Indole Loss: Hypertensive Link Between Dysbiosis and Diastolic Heart Failure.
    Circ Res. 2026;138:e328284.
    PubMed    
    
    
    
19. ZAKARAUSKAS-SETH BI, Forcari G, Anandakumar H, Kotlar-Goldaper I, et al
    Indole-3 Acetate Limits Dysbiosis-Driven Diastolic Failure via Hcrt Neurons.
    Circ Res. 2026;138:e326990.
    PubMed     Abstract available
    
    
    February 2026
20. TADOKORO T, Li H, Gan P, Xu Z, et al
    Ablation of PKCalpha Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure.
    Circ Res. 2026 Feb 20. doi: 10.1161/CIRCRESAHA.125.326738.
    PubMed     Abstract available
    
    
    January 2026
21. CARLEY AN, Maurya SK, Maurya CK, Wang Y, et al
    CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress That Enables Rescue by Gene Transfer.
    Circ Res. 2026;138:e327403.
    PubMed     Abstract available
    
    
    
22. HAYES JB, Choudhary D, Ritter D, Neininger-Castro AC, et al
    Nonmuscle alpha-Actinin-4 Couples Sarcomere Function to Cardiac Remodeling.
    Circ Res. 2026;138:e326412.
    PubMed     Abstract available
    
    
    December 2025
23. CHEN M, Wang Z, Li J, Teng P, et al
    Histone Lactylation Promotes Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Regulating TGFB2 Expression.
    Circ Res. 2025 Dec 11. doi: 10.1161/CIRCRESAHA.125.326185.
    PubMed     Abstract available
    
    
    October 2025
24. PARTHIBAN P, Barrow F, Wang H, Chalise U, et al
    Macrophage-Derived CCL24 Promotes Cardiac Fibrosis Via Fibroblast CCR3.
    Circ Res. 2025;137:1140-1156.
    PubMed     Abstract available
    
    
    September 2025
25. ELBATREEK MH, Lefer DJ
    Unlocking Mitochondrial Potential: DWORF to the Rescue in Heart Failure.
    Circ Res. 2025;137:1089-1091.
    PubMed    
    
    
    
26. YUCEL D, Ferreira de Araujo N, Souza-Neto F, Smith C, et al
    Septin4 Regulates Cardiac Fibrosis After Pressure Overload.
    Circ Res. 2025;137:1117-1132.
    PubMed     Abstract available
    
    
    
27. BRITO-ESTRADA O, Kuwabara Y, Gibson AM, Hassel KR, et al
    DWORF Gene Therapy Improves Cardiac Calcium Handling and Mitochondrial Function.
    Circ Res. 2025;137:1072-1088.
    PubMed     Abstract available
    
    
    
28. LI Z, LaPenna KB, Gehred ND, Yu X, et al
    Dysregulated Protein s-Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2025 Sep 17. doi: 10.1161/CIRCRESAHA.124.326042.
    PubMed     Abstract available
    
    
    
29. WU H, Zhuang Y, Yue Y, Liu J, et al
    SPOP Is a Key Trigger of Pathological Cardiac Hypertrophy and Heart Failure.
    Circ Res. 2025 Sep 15. doi: 10.1161/CIRCRESAHA.125.326129.
    PubMed     Abstract available
    
    
    August 2025
30. PALACIOS-MERINO J, Lara-Pezzi E
    Cutting Loose to Hold on: A Feedback Loop Between GPLD1 and uPAR in Heart Failure.
    Circ Res. 2025;137:584-586.
    PubMed    
    
    
    
31. KNEUER JM, Muller M, Erbe S, Kokot KE, et al
    Circulating Immune Cell Signature Analysis in HFpEF Across Species.
    Circ Res. 2025;137:682-698.
    PubMed     Abstract available
    
    
    
32. VENKATESAN T, Toumpourleka M, Niewiadomska M, Farhat K, et al
    Vagal Stimulation Rescues HFpEF by Altering Cardiac Resident Macrophage Function.
    Circ Res. 2025;137:664-681.
    PubMed     Abstract available
    
    
    
33. PERALTA TM, Zelarayan LC
    Dot1L-H3K79me2-Tbx6 Axis: A Novel Therapeutic Target for Preventing Cardiac Failure.
    Circ Res. 2025;137:513-515.
    PubMed    
    
    
    July 2025
34. YU W, Guo Z, Liang H, Ma D, et al
    GPLD1 Attenuates Heart Failure via Dual Membrane Localization to Inhibit uPAR.
    Circ Res. 2025 Jul 9. doi: 10.1161/CIRCRESAHA.124.325623.
    PubMed     Abstract available
    
    
    
35. SUBRAMANIAN V, Tucker WJ, Peters AE, Upadhya B, et al
    Cardiovascular Aging and Exercise: Implications for Heart Failure Prevention and Management.
    Circ Res. 2025;137:205-230.
    PubMed     Abstract available
    
    
    
36. LEWIS GD, Tada A, Landsteiner I, Borlaug BA, et al
    Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.
    Circ Res. 2025;137:290-315.
    PubMed     Abstract available
    
    
    
37. MOUNSEY LA, Guo M, Lau ES, Ho JE, et al
    Exercise Training in Heart Failure: Clinical Benefits and Mechanisms.
    Circ Res. 2025;137:273-289.
    PubMed     Abstract available
    
    
    June 2025
38. PEPIN ME, Konrad PJM, Nazir S, Bazgir F, et al
    Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF.
    Circ Res. 2025;136:1564-1578.
    PubMed     Abstract available
    
    
    May 2025
39. CALLER T, Moore KJ, Lehmann LH, Wu SM, et al
    Insights Into Heart-Tumor Interactions in Heart Failure.
    Circ Res. 2025;136:1262-1285.
    PubMed     Abstract available
    
    
    
40. JUGUILON C, Khosravi R, Radisic M, Wu JC, et al
    In Vitro Modeling of Interorgan Crosstalk: Multi-Organ-on-a-Chip for Studying Cardiovascular-Kidney-Metabolic Syndrome.
    Circ Res. 2025;136:1476-1493.
    PubMed     Abstract available
    
    
    
41. SALYER LG, Wang Y, Ma X, Foryst-Ludwig A, et al
    Modulating the Secretome of Fat to Treat Heart Failure.
    Circ Res. 2025;136:1363-1381.
    PubMed     Abstract available
    
    
    
42. SNELSON M, R Muralitharan R, Liu CF, Marko L, et al
    Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure.
    Circ Res. 2025;136:1382-1406.
    PubMed     Abstract available
    
    
    
43. LEE CJM, Kosyakovsky LB, Khan MS, Wu F, et al
    Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos.
    Circ Res. 2025;136:1170-1207.
    PubMed     Abstract available
    
    
    
44. KALLIKOURDIS M, Cochran JD, Walsh K, Condorelli G, et al
    Contributions of Noncardiac Organ-Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives.
    Circ Res. 2025;136:1208-1232.
    PubMed     Abstract available
    
    
    
45. SCHIATTARELLA GG, Kontaridis MI
    Interorgan Crosstalk in Heart Failure and Cardiometabolic Diseases: A Compendium.
    Circ Res. 2025;136:1167-1169.
    PubMed    
    
    
    
46. NOELS H, van der Vorst EPC, Rubin S, Emmett A, et al
    Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure.
    Circ Res. 2025;136:1306-1334.
    PubMed     Abstract available
    
    
    
47. KOAY YC, McIntosh B, Ng YH, Cao Y, et al
    The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD(+) Therapy in HFpEF.
    Circ Res. 2025;136:1113-1130.
    PubMed     Abstract available
    
    
    
48. COSTANTINO S, Mohammed SA, Ambrosini S, Telesca M, et al
    Chromatin Rewiring by SETD2 Drives Lipotoxic Injury in Cardiometabolic HFpEF.
    Circ Res. 2025;136:1079-1095.
    PubMed     Abstract available
    
    
    March 2025
49. GHAZAL R, Wang M, Liu D, Tschumperlin DJ, et al
    Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure.
    Circ Res. 2025;136:773-802.
    PubMed     Abstract available
    
    
    
50. HAN X, Shi Q, Tu Y, Zhang J, et al
    Cardiomyocyte PRL2 Promotes Cardiac Hypertrophy via Directly Dephosphorylating AMPKalpha2.
    Circ Res. 2025;136:645-663.
    PubMed     Abstract available
    
    
    December 2024
51. MARTINI E, Cremonesi M, Felicetta A, Serio S, et al
    Autoimmune-Like Mechanism in Heart Failure Enables Preventive Vaccine Therapy.
    Circ Res. 2024 Dec 4. doi: 10.1161/CIRCRESAHA.124.324999.
    PubMed     Abstract available
    
    
    October 2024
52. YOSHII A, McMillen TS, Wang Y, Zhou B, et al
    Blunted Cardiac Mitophagy in Response to Metabolic Stress Contributes to HFpEF.
    Circ Res. 2024;135:1004-1017.
    PubMed     Abstract available
    
    
    September 2024
53. STROCCHI S, Liu L, Wang R, Haseli SP, et al
    Systems Biology Approach Uncovers Candidates for Liver-Heart Interorgan Crosstalk in HFpEF.
    Circ Res. 2024;135:873-876.
    PubMed    
    
    
    
54. DELAUNAY M, Jebessa ZH, McKinsey TA
    Cyclophilin(g) a Knowledge Gap in Heart Failure Pathogenesis.
    Circ Res. 2024;135:774-776.
    PubMed    
    
    
    
55. MUNRO ML, Gonano LA
    On the Mend: Atrial Tubulogenesis After Tachypacing-Induced Heart Failure.
    Circ Res. 2024;135:755-757.
    PubMed    
    
    
    
56. SIGLE M, Rohlfing AK, Cruz Santos M, Kopp T, et al
    Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts.
    Circ Res. 2024;135:758-773.
    PubMed     Abstract available
    
    
    August 2024
57. SANTIAGO PADILLA L, Schiattarella GG
    Targeting HFpEF: Unlocking the Potential of Glucagon Receptor Blockade.
    Circ Res. 2024;135:629-631.
    PubMed    
    
    
    
58. BERGER JH, Matsuura TR, Bowman CE, Taing R, et al
    SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice.
    Circ Res. 2024;135:632-634.
    PubMed    
    
    
    
59. CALDWELL JL, Clarke JD, Smith CER, Pinali C, et al
    Restoring Atrial T-Tubules Augments Systolic Ca Upon Recovery From Heart Failure.
    Circ Res. 2024 Aug 14. doi: 10.1161/CIRCRESAHA.124.324601.
    PubMed     Abstract available
    
    
    
60. PAVELEC CM, Young AP, Luviano HL, Orrell EE, et al
    Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy.
    Circ Res. 2024;135:503-517.
    PubMed     Abstract available
    
    
    July 2024
61. GAO C, Xiong Z, Liu Y, Wang M, et al
    Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jul 16. doi: 10.1161/CIRCRESAHA.124.324706.
    PubMed     Abstract available
    
    
    
62. LEE CJM, Foo RS
    TRIM35: A Proposed Gateway to p53-Induced Heart Failure Pathogenesis.
    Circ Res. 2024;135:314-316.
    PubMed    
    
    
    
63. HINTON A JR, Claypool SM, Neikirk K, Senoo N, et al
    Mitochondrial Structure and Function in Human Heart Failure.
    Circ Res. 2024;135:372-396.
    PubMed     Abstract available
    
    
    June 2024
64. ROMAN B, Mastoor Y, Sun J, Chapoy Villanueva H, et al
    MICU3 Regulates Mitochondrial Calcium and Cardiac Hypertrophy.
    Circ Res. 2024;135:26-40.
    PubMed     Abstract available
    
    
    
65. LORENZANA-CARRILLO MA, Tejay S, Nanoa J, Huang G, et al
    TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure.
    Circ Res. 2024 Jun 11. doi: 10.1161/CIRCRESAHA.123.324202.
    PubMed     Abstract available
    
    
    
66. MALLAREDY V, Roy R, Cheng Z, Gurrala CT, et al
    Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.
    Circ Res. 2024 Jun 7. doi: 10.1161/CIRCRESAHA.123.324110.
    PubMed     Abstract available
    
    
    
67. ALCAIDE P, Kallikourdis M, Emig R, Prabhu SD, et al
    Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction.
    Circ Res. 2024;134:1752-1766.
    PubMed     Abstract available
    
    
    May 2024
68. LIEM DA, Olivera da Silva H, Romero E, Rocha P, et al
    Association of Neighborhood and Environmental Factors with Clinical Phenotypes and Outcomes in Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2024 May 17. doi: 10.1161/CIRCRESAHA.124.324429.
    PubMed    
    
    
    April 2024
69. QASIM H, Rajaei M, Xu Y, Reyes-Alcaraz A, et al
    AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
    Circ Res. 2024;134:1006-1022.
    PubMed     Abstract available
    
    
    March 2024
70. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
    Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
    Circ Res. 2024;134:675-694.
    PubMed     Abstract available
    
    
    
71. CURAJ A, Vanholder R, Loscalzo J, Quach K, et al
    Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
    Circ Res. 2024;134:592-613.
    PubMed     Abstract available
    
    
    February 2024
72. KAMRADT ML, Makarewich CA
    CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
    Circ Res. 2024;134:442-444.
    PubMed    
    
    
    
73. VACCA A, Schiattarella GG
    From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
    Circ Res. 2024;134:390-392.
    PubMed    
    
    
    January 2024
74. WANG YC, Koay YC, Pan C, Zhou Z, et al
    Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jan 24. doi: 10.1161/CIRCRESAHA.123.322381.
    PubMed     Abstract available
    
    
    December 2023
75. STEGE NM, Eijgenraam TR, Oliveira Nunes Teixeira V, Feringa AM, et al
    DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Circ Res. 2023;133:1006-1021.
    PubMed     Abstract available
    
    
    November 2023
76. DAI Z, Thorp EB
    New Way to Study Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:899-901.
    PubMed    
    
    
    
77. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
    Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:885-898.
    PubMed     Abstract available
    
    
    
78. KWAN Z, Paulose Nadappuram B, Leung MM, Mohagaonkar S, et al
    Microtubule-Mediated Regulation of beta(2)AR Translation and Function in Failing Hearts.
    Circ Res. 2023;133:944-958.
    PubMed     Abstract available
    
    
    October 2023
79. LIU D, Wang M, Murthy V, McNamara DM, et al
    Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis.
    Circ Res. 2023;133:810-825.
    PubMed     Abstract available
    
    
    September 2023
80. SERIO S, Pagiatakis C, Musolino E, Felicetta A, et al
    Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis.
    Circ Res. 2023;133:687-703.
    PubMed     Abstract available
    
    
    July 2023
81. 
    Correction to: SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2023;133:e48.
    PubMed    
    
    
    
82. TANG X, Zhao S, Liu J, Liu X, et al
    Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation.
    Circ Res. 2023;133:220-236.
    PubMed     Abstract available
    
    
    
83. DAI Y, Ignatyeva N, Xu H, Wali R, et al
    An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes.
    Circ Res. 2023;133:e19-e46.
    PubMed     Abstract available
    
    
    June 2023
84. FATKIN D, Ohanian M, Brown KJ
    A Novel Role for FKBP5 in Atrial Cardiomyopathy.
    Circ Res. 2023;133:45-47.
    PubMed    
    
    
    
85. SANCHEZ-ALONSO JL, Fedele L, Copier JS, Lucarelli C, et al
    Functional LTCC-beta(2)AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure.
    Circ Res. 2023 Jun 14. doi: 10.1161/CIRCRESAHA.123.322508.
    PubMed     Abstract available
    
    
    May 2023
86. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
    Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
    Circ Res. 2023;132:1468-1485.
    PubMed     Abstract available
    
    
    
87. BOULOS PK, Freeman SV, Henry TD, Mahmud E, et al
    Interaction of COVID-19 With Common Cardiovascular Disorders.
    Circ Res. 2023;132:1259-1271.
    PubMed     Abstract available
    
    
    April 2023
88. NGUYEN TD, Schulze PC
    Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Circ Res. 2023;132:1034-1049.
    PubMed     Abstract available
    
    
    
89. WU Z, Lohmoller J, Kuhl C, Wehrle K, et al
    Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk.
    Circ Res. 2023;132:1084-1100.
    PubMed     Abstract available
    
    
    March 2023
90. MATSUURA TR, Puchalska P, Crawford PA, Kelly DP, et al
    Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
    Circ Res. 2023;132:882-898.
    PubMed     Abstract available
    
    
    
91. YE S, Huang H, Han X, Luo W, et al
    Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Circ Res. 2023;132:707-722.
    PubMed     Abstract available
    
    
    
92. CANNAVO A, Jun S, Rengo G, Marzano F, et al
    beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
    Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
    PubMed     Abstract available
    
    
    
93. HUGHES A, Shandhi MMH, Master H, Dunn J, et al
    Wearable Devices in Cardiovascular Medicine.
    Circ Res. 2023;132:652-670.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum